Single-arm, non-randomized, prospective, multi-center study with the Bard® LifeStent® Vascular Stent Delivery. (BARD)
Basic data for this project
Type of project: Individual project
Duration at the University of Münster: 01/08/2010 - 31/07/2013
Description
In this study the Bard® LifeStent® Vascular Stent Delivery System is used in subjects with lifestyle-limiting claudication or ischemic rest pain that are candidates for percutaneous transluminal angioplasty (PTA) and stenting with lesion(s) in the infra-inguinal segment (superficial femoral artery (SFA) and/or proximal popliteal artey). Subjects will be treated with PTA followed by implantation of the Bard® LifeStent® Vascular Stent. Clinical follow-up for all subjects will be performed prior to hospital discharge, 30 days, 12-, 24-, and 36-months post index procedure.
Keywords: Kathetertechnik; Spinalballon
Funding identifier: BPV-09-006
Funder / funding scheme:
- Bard Peripheral Vascular Inc. (Bard)
Project management at the University of Münster
| Reinecke, Holger | Klinik für Kardiologie I |
Applicants from the University of Münster
| Reinecke, Holger | Klinik für Kardiologie I |
Research associates from the University of Münster
| Meyborg, Matthias | Department for Cardiovascular Medicine |